Cardiovascular Assessment of Pediatric Cancer Survivors

Completed

• Conditions: Left Ventricular Dysfunction; Heart Failure

• Registration Number: NCT05939089
• Lead Sponsor: Istanbul University

Brief Summary

The goal of this observational study is to evaluate cardiac and vascular health status of pediatric cancer survivors.

Detailed Description

All pediatric cancer survivors were evaluated with cardiological examination, ECG, transthoracic echocardiography (transesophageal echocardiography when required), NT-proBNP, cTnI, kidney function tests, liver function tests, fasting blood glucose, cholesterol panel, iron, iron binding capacity, ferritin, transferrin saturation, B12, vitamin D, folic acid, urinanalysis, hemogram and a questionnaire about living with heart failure.

Study Timeline

• Study Start: 2023-01-01
• Primary Completion: 2023-06-15
• Study Completion: 2023-06-22
• Study First Submitted: 2023-06-24
• Status Verified: 2023-07
• Study First Submitted QC: 2023-07-08
• Last Update Submitted: 2023-07-08
• Study First Posted: 2023-07-11
• Last Update Posted: 2023-07-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

• Diagnosed cancer at pediatric age

Exclusion Criteria

• Having cancer after 18 years of age

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of LV Dysfunction	From the first visit at cardio-oncology division through study completion, an average of 2 years	Echocardiographic evaluation of left ventricular functions

Trial Locations

Locations (1)

Istanbul Faculty of Medicine; 🇹🇷 Fatih, Istanbul, Turkey